Enhancing Interpretability of Cancer Clinical Trial Results

This comparative clinical study discusses problems with conventional trial design and analysis and presents alternatives to the hazard ratio using a recent immunotherapy study as an illustrative example.

from Cancer via ola Kala on Inoreader http://ift.tt/2wJexof
via IFTTT